Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.22% is 47% below its 1-year average of 0.41%, near the low end of its 1-year range (0.22%–0.61%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation.
Limited quarterly history available
Debt to Assets needs at least three reported quarters before a meaningful chart is shown.
DEBT TO ASSETS RATIO
0.22%
DEBT TO ASSETS RATIO AVG TTM
N/A
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+119.33%
vs the sector median at left
Hemab Therapeutics Holdings, Inc. Common Stock
Market Cap
$1.38B
Debt to Assets Ratio
0.22%
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG) | $1.38B | 0.22% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.39B | 0.01% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | 0.03% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.34B | 0.11% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | 0.00% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 0.85% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 0.02% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.48B | 0.11% |
| Kardigan, Inc. (KARD)vs › | $1.27B | 0.02% |
Debt/Assets
0.2%
Debt/Equity
0.00
Current Ratio
35.85
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.22% |
| 2026-03-31 | 0.61% |
